Roundtable discussion ‘Managing P. aeruginosa exacerbations’


Source: International Congress 2014 – Roundtable discussion ‘Managing P. aeruginosa exacerbations’
Disease area: Airway diseases, Respiratory infections

Webcast

Rating: 3
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Roundtable discussion ‘Managing P. aeruginosa exacerbations’. International Congress 2014 – Roundtable discussion ‘Managing P. aeruginosa exacerbations’

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

Jorge Alberto Chancafe Morgan - 22.04.2015 16:31
Excellent presentation!!!.

Jorge Alberto Chancafe Morgan - 31.03.2015 03:01
No videos are available!!!
You must Login to comment this presentation.


Related content which might interest you:
Roundtable discussion ‘Managing chronic P. aeruginosa infection’
Source: International Congress 2014 – Roundtable discussion ‘Managing chronic P. aeruginosa infection’
Year: 2014

Roundtable discussion ‘Managing P. aeruginosa at first isolation’
Source: International Congress 2014 – Roundtable discussion ‘Managing P. aeruginosa at first isolation’
Year: 2014

Interactive case study ‘Controversies in managing P. aeruginosa in non-CF bronchiectasis’
Source: International Congress 2014 – Bayer Expert Forum at ERS 2014 ‘Infection, Exacerbation and Colonisation: Managing Pseudomonas aeruginosa in non-CF Bronchiectasis’ – Full Video
Year: 2014

Acute exacerbations of COPD due to pseudomonas aeruginosa: Impact of antimicrobial resistance
Source: International Congress 2015 – Infection in COPD: different aspects of the host/pathogen balance
Year: 2015



Pseudomonas aeruginosa infection and exacerbations in bronchiectasis: more questions than answers
Source: Eur Respir J, 51 (2) 1702497; 10.1183/13993003.02497-2017
Year: 2018



Bayer Expert Forum at ERS 2014 ‘Infection, Exacerbation and Colonisation: Managing Pseudomonas aeruginosa in non-CF Bronchiectasis’ – Full Video
Source: International Congress 2014 – Bayer Expert Forum at ERS 2014 ‘Infection, Exacerbation and Colonisation: Managing Pseudomonas aeruginosa in non-CF Bronchiectasis’ – Full Video
Year: 2014

Pseudomonas aeruginosa colonisation in patients without bronchiectasis
Source: International Congress 2014 – Clinical management of lung diseases: from bronchi to pleura
Year: 2014

Pseudomonas aeruginosa pneumonia in the community
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014


COPD and pseudomonas aeruginosa, an association
Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections
Year: 2014


A comprehensive analysis of the impact of pseudomonas aeruginosa colonisation in adult bronchiectasis
Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives
Year: 2015


Pseudomonas aeruginosa eradication therapy on Cystic Fibrosis- Guideline and clinical routine
Source: International Congress 2018 – Cystic fibrosis in adults: current research
Year: 2018


Influence of biofim on the bronchial microbiome in COPD patients colonized or infected by pseudomonas aeruginosa
Source: International Congress 2015 – Advances from translational research in respiratory infections
Year: 2015

Persistence and genetic adaptation of Pseudomonas aeruginosa in patients with COPD.
Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond
Year: 2020




Pseudomonas aeruginosa and antibiotic resistance in acute exacerbations of COPD (AECOPD)
Source: Annual Congress 2009 - Respiratory infection caused by Pseudomonas aeruginosa
Year: 2009


Aminoglycoside use for pseudomonas aeruginosa in bronchiectasis
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014


Enterobacteriaceae and Pseudomonas aeruginosa in community-acquired pneumonia: the reality after a decade of uncertainty?
Source: Eur Respir J 2010; 35: 473-474
Year: 2010


Bronchiectasis exacerbations by Pseudomonas aeruginosa: differences and similarities
Source: International Congress 2018 – The airway microbiome across the spectrum of airway disease
Year: 2018



Specific immune response against pseudomonas aeruginosa and haemophilus influenzae in severe COPD
Source: International Congress 2016 – Clinical and microbiological aspects of infections in COPD patients
Year: 2016

The clinical impact of pseudomonas aeruginosa eradication in bronchiectasis in a Dutch center of expertise
Source: International Congress 2018 – Bronchiectasis: phenotypes, endotypes and new therapies
Year: 2018